logo image
search icon
ADME Toxicology Testing Market

ADME Toxicology Testing Market, Share & Trends Analysis Report, By Type of Services (Absorption, Distribution, Metabolism, Excretion), Type of Assays (Batch / Fed-Batch, Continuous), Type of Molecule (Biologics, Small Molecules), End User, Therapeutic Areas, By Region, and Segment Forecasts, 2024-2031

Report ID : 2596 | Published : 2024-10-22 | Pages: 170 | Format: PDF/EXCEL

The ADME Toxicology Testing Market Size is valued at USD 3.82 Bn in 2023 and is predicted to reach USD 7.12 Bn by the year 2031 at an 8.3% CAGR during the forecast period for 2024-2031.

ADME

ADME, which stands for Absorption, Distribution, Metabolism, and Excretion, refers to the studies designed to investigate how a chemical, such as a drug compound, is processed by a living organism. These studies help determine how the drug is absorbed into the bloodstream, distributed throughout the body, metabolized into different substances, and excreted. Toxicology tests, which are often part of this process, provide insights into the potential adverse effects of the drug. When combined, these studies yield the acronym ADMET, which encompasses both the pharmacokinetic and toxicological evaluation necessary for assessing the safety and efficacy of new drug candidates.

ADME toxicology testing helps to identify drugs or chemicals that are likely to be toxic, have poor bioavailability (i.e., they are not well absorbed by the body), or interact with other drugs. Additionally, ADME testing aids in optimizing the dosing of drugs. By addressing these critical aspects, ADME toxicology testing ensures that new drugs are safe and effective for patients. It includes studying acute, chronic, and sub-chronic toxicity, genotoxicity, carcinogenicity, reproductive and developmental toxicity, and other specific toxicological endpoints.

The application of ADME toxicology testing in drug development and chemical safety assessment is multifaceted and crucial. It is used to determine drugs or chemicals likely to be toxic, preventing potential harm to patients and identify potential interactions with other drugs, minimizing adverse effects.

Competitive Landscape

Some of the Major Key Players in the ADME Toxicology Testing Market are

  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Agilent Technologies, Inc.
  • Charles River Laboratories
  • RTI International
  • Eurofins Scientific
  • Evotec
  • Galapagos
  • Tecan Group
  • GVK Biosciences
  • Pharmaron
  • Pharmaceutical Product Development (PPD)
  • Sai Life Sciences
  • Shanghai Medicilon
  • Syngene International
  • WuXi AppTec

Market Segmentation:

The is segmented based on the type of services, type of assays, type of molecule, end user, and therapeutic areas. By Type of Services segmented into absorption, distribution, metabolism, and excretion. Based on the Type of Assays segmented into batch / fed-batch, continuous. Therapeutic Areas, the market is categorized into blood disorder, cardiovascular disorder, gastrointestinal and vascular disorder, hormonal disorder, infectious diseases, immunological disorders, mental disorders, metabolic disorders, neurological disorders, oncology disorders, respiratory disorders. Type of Molecule segmented into biologics, small molecules.  End User segmented into pharmaceutical and biotechnology companies, academic / research institutes.

The Oncology Disorders Segment is Expected to have the highest growth rate during the forecast period

Based on Therapeutic Areas, the market is categorized into blood disorder, cardiovascular disorder, gastrointestinal and vascular disorder, hormonal disorder, infectious diseases, immunological disorders, mental disorders, metabolic disorders, neurological disorders, oncology disorders, respiratory disorders. Among these, the oncology disorders segment is expected to have the highest growth rate during the forecast period. This is because cancer drug development is a highly active and rapidly evolving area of research and development. Oncology drugs often require extensive ADME testing to ensure they are effectively absorbed, distributed, metabolized, and excreted, as well as to understand their potential toxicological effects. The high prevalence and significant clinical need for effective cancer treatments drive substantial investment and focus in this segment, leading it to dominate the ADME toxicology testing market.

The Batch / Fed-Batch Segment Dominate the Market

Based on type of Assay, the segment divided into batch / fed-batch, continuous form. Among these, the batch / fed-batch segment dominates the market during the forecast period. Batch and fed-batch processes are more commonly used in the production and testing of pharmaceuticals, including ADME toxicology studies, because they offer greater control over experimental conditions and are well-suited to the scale of most laboratory and preclinical studies. These methods allow for precise adjustments to be made to the testing environment and are easier to manage compared to continuous processes, which are more complex and typically used for large-scale manufacturing rather than initial testing and development phases.

North America Have the Largest Market Share During Forecast Period

North America, particularly the United States, has a highly developed healthcare infrastructure that supports extensive research and development activities. The region is home to many of the world's leading pharmaceutical companies, which conduct extensive drug development and testing. North America is at the forefront of adopting advanced technologies and methodologies in ADME toxicology testing, improving efficiency and outcomes. The availability of a highly skilled workforce in biomedical and pharmaceutical sciences enhances the capacity for high-quality ADME testing.

Recent Developments:

  • In Jun 2024, Charles River Laboratories, The CARACAL working group of the European Commission has put out a draft proposal that would amend the current REACH laws concerning ADME data. The subject of changing the most dangerous substance or low tonnage criteria for endocrine disruptors is still very much in the spotlight. These days, chemical makers are also worried about the effects of modifications to ADME reporting standards.

ADME Toxicology Testing Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 3.82 Bn

Revenue Forecast In 2031

USD 7.12 Bn

Growth Rate CAGR

CAGR of 8.3% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Type of Services, Type of Assays, Type of Molecule, End User, Therapeutic Areas

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia

Competitive Landscape

Thermo Fisher Scientific Inc., Promega Corporation, Agilent Technologies, Inc., Charles River Laboratories, RTI International., Eurofins Scientific, Evotec, Galapagos, Tecan Group, GVK Biosciences, Pharmaron, Pharmaceutical Product Development (PPD), Sai Life Sciences, Shanghai Medicilon, Syngene International

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary

Chapter 3. Global ADME Toxicology Testing Market Snapshot

Chapter 4. Global ADME Toxicology Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: Type of Services Estimates & Trend Analysis
5.1. Type of Services & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Services:

5.2.1. Absorption
5.2.2. Distribution
5.2.3. Metabolism
5.2.4. Excretion

Chapter 6. Market Segmentation 2: Type of Assays Estimates & Trend Analysis
6.1. Type of Assays & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Assays:

6.2.1. Batch / Fed-Batch
6.2.2. Continuous

Chapter 7. Market Segmentation 3: Type of Molecules Estimates & Trend Analysis
7.1. Type of Molecules & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Molecules:

7.2.1. Biologics
7.2.2. Small Molecules

Chapter 8. Market Segmentation 4: End Users Estimates & Trend Analysis
8.1. End Users & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following End Users:

8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. Academic / Research Institutes

Chapter 9. Market Segmentation 5: Therapeutic Areas Estimates & Trend Analysis
9.1. Therapeutic Areas & Market Share, 2019 & 2031
Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Therapeutic Areas:

9.1.1. Blood Disorder
9.1.2. Cardiovascular Disorder
9.1.3. Gastrointestinal and Vascular Disorder
9.1.4. Hormonal Disorder
9.1.5. Infectious Diseases
9.1.6. Immunological Disorders
9.1.7. Mental Disorders
9.1.8. Metabolic Disorders
9.1.9. Neurological Disorders
9.1.10. Oncology Disorders
9.1.11. Respiratory Disorders

Chapter 10. ADME Toxicology Testing Market Segmentation 4: Regional Estimates & Trend Analysis

10.1. North America
10.1.1. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.1.2. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.1.3. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.1.4. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.1.5. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.1.6. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.2. Europe
10.2.1. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.2.2. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.2.3. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.2.4. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.2.5. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.2.6. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts xx6, 2024-2031
10.2.7. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.3. Asia Pacific
10.3.1. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.3.2. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.3.3. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.3.4. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.3.5. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.3.6. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.4. Latin America
10.4.1. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.4.2. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.4.3. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.4.4. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.4.5. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.4.6. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.5. Middle East & Africa
10.5.1. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.5.2. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.5.3. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.5.4. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.5.5. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Therapeutic Areas, 2024-2031
10.5.6. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles

11.2.1. Thermo Fisher Scientific Inc.
11.2.2. Promega Corporation
11.2.3. Agilent Technologies, Inc.
11.2.4. Charles River Laboratories
11.2.5. RTI International
11.2.6. Eurofins Scientific
11.2.7. Evotec
11.2.8. Galapagos
11.2.9. Tecan Group

11.2.10. GVK Biosciences
11.2.11. Pharmaron
11.2.12. Pharmaceutical Product Development (PPD)
11.2.13. Sai Life Sciences
11.2.14. Shanghai Medicilon
11.2.15. Syngene International
11.2.16. WuXi AppTec

Segmentation of ADME Toxicology Testing Market

Global ADME Toxicology Testing Market -Type of Services          

  • Absorption
  • Distribution
  • Metabolism
  • Excretion

ADME

Global ADME Toxicology Testing Market – Type of Assays          

  • Batch / Fed-Batch
  • Continuous

Global ADME Toxicology Testing Market – Type of Molecules          

  • Biologics
  • Small Molecules

Global ADME Toxicology Testing Market – End Users       

  • Pharmaceutical and Biotechnology Companies
  • Academic / Research Institutes

Global ADME Toxicology Testing Market – Therapeutic Areas          

  • Blood Disorder
  • Cardiovascular Disorder
  • Gastrointestinal and Vascular Disorder
  • Hormonal Disorder
  • Infectious Diseases
  • Immunological Disorders
  • Mental Disorders
  • Metabolic Disorders
  • Neurological Disorders
  • Oncology Disorders
  • Respiratory Disorders

Global ADME Toxicology Testing Market – By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the ADME Toxicology Testing Market Size?

The ADME Toxicology Testing Market is expected to grow at an 8.3% CAGR during the forecast period for 2024-2031.

Thermo Fisher Scientific Inc., Promega Corporation, Agilent Technologies, Inc., Charles River Laboratories, RTI International., Eurofins Scientific, E

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach